Illumina, Inc

Competitive intelligence and market positioning for Illumina, Inc across 3 market research reports.

3 Reports

2 Industries

HealthcarePharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics

Reports Featuring Illumina, Inc

Bioengineering

Healthcare·Market: $295.88B·CAGR: 17.53

Personalized Cancer Medicine

Healthcare·Market: $198.16B·CAGR: 10.80

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

Explore More Companies

Browse competitive intelligence on all key market players across our research coverage.

View all companies